Girija Rout

Girija Rout

Active Director Director DIN 09375541
DIN 09375541 First appointment Oct 2021 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Oct 2021
Shareholding value Locked Premium profile

About Girija Rout

Girija Rout has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Xenex Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

DIN 09375541
Primary Designation Director
First Appointment 28 Oct 2021
Oldest Company Age 16 yrs

Current companies

Company Designation Appointment Founded Status
Xenex Biotech Private Limited U51397OR2010PTC012039
Director 28 Oct 2021 2010 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Xenex Biotech Private Limited
Premium access

Shareholding and investment profile for Girija Rout

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Girija Rout

Girija Rout has 4 years in corporate governance. Holds Director role. Currently with 1 company, including Xenex Biotech Private Limited. Engaged in Technology. Contributes to corporate operations.

Girija Rout is associated with 1 company as Director.

Girija Rout has expertise in Technology.

Girija Rout has 4 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available